Jon Jyoti Sahariah | Medicinal Chemistry | Research Excellence Award

Published-on by Indian Scientist

Research Excellence Award

Jon Jyoti Sahariah
Dibrugarh University, India

Jon Jyoti Sahariah
Affiliation Dibrugarh University
Country India
Scopus ID 57225212218
Documents 19
Citations 125
h-index 6
Subject Area Medicinal Chemistry
Event Indian Scientist Awards

Jon Jyoti Sahariah is an academic researcher affiliated with Dibrugarh University, India, whose scholarly activities are associated with medicinal chemistry, pharmaceutical sciences, drug delivery systems, and therapeutic development. His published research contributions demonstrate engagement with contemporary challenges in drug discovery, targeted therapeutics, and biomedical innovation. Through peer-reviewed publications, citation impact, and interdisciplinary collaborations, he has contributed to advancing scientific understanding within medicinal chemistry and related biomedical disciplines.[1]

Abstract

This article presents an academic overview of Jon Jyoti Sahariah and his scholarly contributions within medicinal chemistry and pharmaceutical research. The profile summarizes research interests, publication records, citation metrics, scientific influence, and relevance to recognition through the Research Excellence Award. The assessment is based on publicly available scholarly indicators and peer-reviewed academic outputs.[1]

Keywords

Medicinal Chemistry, Drug Discovery, Pharmaceutical Sciences, Targeted Drug Delivery, Cancer Therapeutics, Liposomal Formulations, Biomedical Research, Therapeutic Development, Scientific Publications, Research Excellence.

Introduction

Medicinal chemistry plays a critical role in the development of novel therapeutic agents and advanced healthcare solutions. Researchers working in this field contribute to the identification, optimization, and evaluation of biologically active compounds for the prevention and treatment of diseases. Jon Jyoti Sahariah’s academic activities align with these objectives through investigations focused on pharmaceutical formulations, drug delivery systems, and therapeutic innovations. His work reflects interdisciplinary collaboration across chemistry, pharmacy, and biomedical sciences.[2]

Research Profile

The scholarly profile of Jon Jyoti Sahariah demonstrates sustained participation in scientific research and publication. According to available bibliometric indicators, his research output includes nineteen indexed documents, 125 citations, and an h-index of six. These metrics indicate measurable academic visibility and engagement within the scientific community. His publications encompass medicinal chemistry, drug delivery technologies, cancer therapeutics, and pharmaceutical innovations.[1]

  • Affiliation with Dibrugarh University, India.
  • Research specialization in medicinal chemistry and pharmaceutical sciences.
  • Indexed publications in peer-reviewed journals.
  • Interdisciplinary collaboration involving drug discovery and therapeutic development.

Research Contributions

Jon Jyoti Sahariah has contributed to studies involving natural bioactive compounds, targeted cancer therapies, liposomal drug delivery systems, and pharmaceutical technologies. Several publications examine mechanisms for improving therapeutic efficacy while reducing adverse effects associated with conventional treatments. Research efforts in these domains contribute to ongoing developments in precision medicine and translational pharmaceutical science.[3]

  • Investigation of natural compounds with therapeutic potential.
  • Research on advanced liposomal drug delivery systems.
  • Contributions to targeted cancer therapy methodologies.
  • Participation in multidisciplinary biomedical research projects.

Publications

Selected scholarly works associated with Jon Jyoti Sahariah include publications addressing cancer chemotherapy, liposomal drug delivery, and medicinal chemistry innovations. Representative studies include highly cited articles focusing on natural bioactive compounds and targeted therapeutic approaches.[3]

  1. Cancer Chemotherapy via Natural Bioactive Compounds.
  2. Advancing Liposomal Doxorubicin for Targeted Cancer Therapy.
  3. Research involving pharmaceutical formulation and drug delivery technologies.
  4. Studies related to medicinal chemistry and therapeutic development.

Research Impact

Research impact can be assessed through publication output, citation frequency, collaborative scholarship, and relevance to scientific advancement. The citation record associated with Jon Jyoti Sahariah indicates that his work has been referenced by researchers in related fields, reflecting scholarly engagement and knowledge dissemination. Contributions to pharmaceutical sciences and medicinal chemistry support ongoing scientific dialogue regarding improved therapeutic interventions.[1]

Award Suitability

The Research Excellence Award recognizes researchers demonstrating meaningful scholarly contributions, scientific productivity, and academic influence. Based on available publication records, citation metrics, and participation in medicinal chemistry research, Jon Jyoti Sahariah exhibits characteristics consistent with the objectives of academic recognition programs. His work contributes to knowledge advancement in pharmaceutical and biomedical sciences while supporting innovation in therapeutic research.[1][4]

Conclusion

Jon Jyoti Sahariah has established a scholarly profile characterized by contributions to medicinal chemistry, drug delivery systems, and pharmaceutical sciences. Through peer-reviewed publications, citation impact, and collaborative scientific efforts, he has participated in research addressing significant healthcare and therapeutic challenges. His academic record supports consideration for professional recognition through the Research Excellence Award and reflects ongoing engagement with scientific advancement.[1]

References

  1. Scopus author details: Jon Jyoti Sahariah, Author ID 57225212218. Scopus. https://www.scopus.com/authid/detail.uri?authorId=57225212218
  2. Cancer chemotherapy via natural bioactive compounds. https://www.benthamdirect.com/content/journals/cddt/10.2174/1570163819666220331095744
  3. From bench to bedside: Advancing liposomal doxorubicin for targeted cancer therapy. https://www.sciencedirect.com/science/article/pii/S2666845925000601
  4. Revolutionizing patient care: 3D printing for customized medical devices and therapeutics. https://link.springer.com/article/10.1007/s44174-025-00324-2

Datta Pawde | Pharmaceutical Analysis | Best Researcher Award

Published-on by Indian Scientist

Dr. Datta Pawde | Pharmaceutical Analysis | Best Researcher Award

Department of Pharmaceutical Sciences,  India

Dr. Datta Maroti Pawde is an academic and researcher in Pharmaceutics, currently serving as an Assistant Professor in Pharmaceutical Sciences at a central university in India. He holds doctoral and postgraduate training from nationally reputed institutes and has teaching experience at a leading deemed university. His research interests focus on advanced drug delivery systems, formulation development, and pharmaceutical technology. He has received prestigious fellowships, international research recognition, and academic honors, reflecting his strong contribution to pharmaceutical education and research.

Citation Metrics (Scopus)

600
500
30
20
10
0

Citations
512

Documents
27

h-index
12

Citations

Documents

h-index

Featured Publications

Rahul Kumar | Pharmaceutical Chemistry | Young Scientist Award

Published-on by Indian Scientist

Mr. Rahul Kumar | Pharmaceutical Chemistry | Young Scientist Award

Vidya University | India

Rahul Kumar is an Assistant Professor in Pharmacy with expertise in Computer-Aided Drug Design and Pharmaceutical Chemistry. He holds professional training in pharmaceutical sciences and contributes to teaching and research in drug discovery, molecular modeling, and computational chemistry. His research focuses on CADD, medicinal chemistry, biosensors, and AI-driven approaches in healthcare. He has authored peer-reviewed publications, book chapters, and patents, and has received national-level research and innovation awards, reflecting a strong commitment to academic excellence and translational research.

Citation Metrics (Scopus)

20
15
10
5
0

Citations
11

h-index
1

Documents
1

Citations

h-index

Documents

Featured Publications

Citation counts are indicative and may vary across databases; all links redirect to open Google Scholar search results.

Anupam Kanti Bag | Pharmacology | Best Researcher Award

Published-on by Indian Scientist

Dr. Anupam Kanti Bag | Pharmacology | Best Researcher Award

Dr. B.C. Roy College of Pharmacy and Allied Health Sciences |India

Dr. Anupam Kanti Bag is an accomplished pharmacology professional with strong academic and research credentials, reflected through 142 citations, an h-index of 3, and 3 i10-index publications, demonstrating consistent scholarly impact. His expertise spans microscopy, molecular biology, behavioral analysis, molecular docking, and network pharmacology, supported by extensive laboratory experience and a solid background in pharmaceutical sciences. He has significantly contributed to innovation through multiple national and international patents in drug formulation, medical device design, and pharmacokinetic enhancement, along with authoring books and contributing chapters in emerging areas of neurodegenerative disease research. His funded research work includes projects focusing on phytochemical formulations and nano-based therapeutic applications. Dr. Bag has served in various academic, administrative, and accreditation roles, including NAAC/NBA coordination, placement operations, exam cell management, and institutional leadership responsibilities across reputed pharmacy colleges. His technical skills extend to tools such as Pyrex, Pymol, Chimera, and Biovia Studio, combined with proficiency in cell culture handling, gene assays, ADR reporting, and laboratory instrumentation. Recognized with awards for academic excellence, mentoring, and scientific presentations, he continues to contribute to the advancement of pharmacology research with dedication to innovation, collaboration, and student development.

Profile: Google Scholar

Featured Publications

Bag, A. K., & Mumtaz, S. M. F. (2013). Hepatoprotective and nephroprotective activity of hydroalcoholic extract of Ipomoea staphylina leaves. Bangladesh Journal of Pharmacology, 8(3), 263–268.

Subramaniyan, V., Shaik, S., Bag, A., Manavalan, G., & Chandiran, S. (2018). Potential action of Rumex vesicarius (L.) against potassium dichromate and gentamicin-induced nephrotoxicity in experimental rats. Pakistan Journal of Pharmaceutical Sciences, 31(2), 509–516.

Mumtaz, S. M. F., Paul, S., & Bag, A. K. (2013). Effect of Sechium edule on chemical-induced kidney damage in experimental animals. Bangladesh Journal of Pharmacology, 8(1), 28–35.

Bag, A. K., & Hiremath, S. R. R. (2023). Neuropathic pain and its management. Indian Journal of Pharmacy Practice, 16(3).

Verma, P., Munirangappa, H., Bag, A. K., & Purushottam, H. (2023). Amelioration of hyperglycemia by hydroalcoholic extract of leaves of Ecbolium viride against experimental type II model in rats.

Ashish Sriram Mishra | Pharmaceutics | Research Excellence Award

Published-on by Indian Scientist

Mr. Ashish Sriram Mishra | Pharmaceutics | Research Excellence Award

SRM College of Pharmacy SRMIST Kattankulathur Chennai | India

Mr. Ashish Sriram Mishra is a dedicated researcher in pharmaceutics with strong expertise in novel drug delivery systems, optimization tools, and formulation science, currently pursuing doctoral research at SRM Institute of Science and Technology. He has completed his postgraduate and undergraduate studies in pharmacy with excellent academic performance, building a solid foundation in biopharmaceutics, pharmacokinetics, and advanced pharmaceutical technology. His research focuses on polymeric nanoparticles, lipid-based carriers, targeted gastrointestinal delivery, stability-indicating analytical methods, and drug repurposing strategies. He has authored impactful scientific publications in reputed journals, contributing an h-index of 3, over 40 citations, and more than 10 documents indexed in leading scholarly databases. His work includes advancements in nanomedicine, inflammation management, analytical method development, and Alzheimer’s disease therapeutic strategies. He has hands-on experience in formulation development, characterization techniques, cell studies, microbial assays, instrumental analysis, and design-based optimization, along with proficiency in scientific writing and laboratory documentation. His contributions to pharmaceutics reflect innovation, precision, and a commitment to translational research. He continues to advance his scientific expertise through active research, scholarly publications, and participation in collaborative academic environments, aiming to contribute significantly to pharmaceutical innovation and therapeutic development.

Profile: Google Scholar 

Featured Publications

Mishra, A. S., Vasanthan, M., & Malliappan, S. P. (n.d.). Drug repurposing: A leading strategy for new threats and targets. ACS Pharmacology & Translational Science, 7(4), 915–932.

Mishra, A. S., Sugumaran, A., & Damodharan, N. (n.d.). Nanoparticulate delivery systems for the effective treatment of COPD. Annals of the Romanian Society for Cell Biology, 25(4), 13892–13904.

Mishra, A. S., & Vasanthan, M. (n.d.). Design and validation of a robust stability-indicating reversed-phase HPLC method for quantification of mesalamine in formulated drug products. BMC Chemistry, 19(1), 303.

Mishra, A. S., Vasanthan, M., & Pandey, C. (n.d.). Comparative in silico human and environmental hazard profiling of ulcerative colitis pharmaceuticals. Environmental Chemistry and Ecotoxicology.

Mishra, A. S., & Vasanthan, M. (n.d.). Ecofriendly analytical quality by design aided RP-HPLC method for the estimation of mesalamine: Greenness, blueness and whiteness appraisal. Microchemical Journal, Article

Ankush Kumar | Medicinal Chemistry | Young Researcher Award

Published-on by Indian Scientist

Mr. Ankush Kumar | Medicinal Chemistry | Young Researcher Award

Chitkara University Punjab | India

Ankush Kumar is a dedicated pharmaceutical researcher whose work spans medicinal chemistry, molecular modeling, and targeted drug design with a strong focus on anticancer therapeutics. He holds a solid academic foundation with qualifications in pharmaceutical chemistry and extensive research training that includes computational drug design, structure-activity exploration, and medicinal insights into heterocyclic scaffolds. His professional experience includes serving as a Junior Research Fellow and working as an Assistant Professor across multiple academic institutions, where he contributed to teaching, mentoring, and research development. His research outputs reflect a strong contribution to oncology-oriented drug discovery, with publications covering molecular targets, biomarkers, EGFR inhibition, heterocyclic synthesis, and computational repurposing studies. He has authored numerous research papers in reputed journals, contributing to a total of 561 citations, supported by an h-index of 6 and i10-index of 4, demonstrating the growing influence of his scientific contributions. His work includes book chapters and multiple peer-reviewed articles that highlight new therapeutic strategies and structural insights into various biological targets. He has received academic distinctions such as top positions in academic competitions and has served as a reviewer for international journals, further reflecting his scholarly engagement. Overall, his research trajectory reflects a commitment to advancing pharmaceutical innovation and precision-driven drug discovery.

Profile: Google Scholar

Featured Publications

Ye, F., Dewanjee, S., Li, Y., Jha, N. K., Chen, Z. S., Kumar, A., Vishakha, Jha, S. K., et al. (2023). Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer. Molecular Cancer, 22(1), 105.

Kumar, A., Sehgal, A., Singh, S., Sharma, N., Yadav, S., Rashid, S., Ali, N., et al. (2023). Understanding the mechanistic pathways and clinical aspects associated with protein and gene based biomarkers in breast cancer. International Journal of Biological Macromolecules, Article 126595.

Zheng, M., Kumar, A., Sharma, V., Sehgal, A., Wal, P., Shinde, N. V., Kawaduji, B. S., et al. (2024). Revolutionizing pediatric neuroblastoma treatment: unraveling new molecular targets for precision interventions. Frontiers in Cell and Developmental Biology, 12, Article 1353860.

Kumar, A., Kumar, B., & Bhatia, R. (2023). Design, synthesis, molecular docking, and biological evaluation of isatin-based fused heterocycles as epidermal growth factor receptor inhibitors. Assay and Drug Development Technologies, 21(5), 222–233.

Kumar, A., Narang, R. K., & Bhatia, R. (2023). Recent advancements in NS5B inhibitors (2011–2021): Structural insights, SAR studies and clinical status. Journal of Molecular Structure, 1293, Article 136272.